Blog

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Blog

Tom Powles on the NADINA trial

Photo of Tom Powles taken from bartscancer.london

May 23, 2024, 13:04

Tom Powles on the NADINA trial

Tom Powles, Director of Barts Cancer Center, shared a post on X:

“The NADINA trial of neoadjuvant ipi/nivo vs adjuvant nivo in melanoma is a plenary ASCO24 . Shorter periods of therapy in responders (neoadjuvant alone) is an important question. Neoadjuvant nivo didn’t work in RCC (PROSPER). PACIFIC2 struggled in lung.”

Tom Powles

Read further.
Source: Tom Powles/X

ASCO24 cancer Melanoma OncoDaily Oncology Tom Powles

Oct 22, 2024, 00:56

Highlights from SIOP 2024 Congress Day 4: 19 Posts Not To Miss

Oct 22, 2024, 00:49

Cathy Eng: It’s a wrap! Another successful GDUGI!

Oct 22, 2024, 00:40

Cristiane D Bergerot: Excited with the collaboration with Rising Tide at SIOG24

Oct 22, 2024, 00:34

Shashi Kant reflects on the Cleveland GU Consortium Meeting

Oct 22, 2024, 00:30

Stephen V Liu: Looking forward to speaking at the lung cancer session of the 42nd CFS meeting

Oct 22, 2024, 00:24

Yelena Janjigian: GDGI's going strong for more than 20 years

Oct 22, 2024, 00:21

Zainab Shinkafi-Bagudu: Grateful to receive the 2024 Dicey Scroggins Distinguished Advocate Award during the IGCS2024

Oct 21, 2024, 20:50

Rebecca Shatsky: UC San Diego Health Moores Cancer Center Advances in Breast Cancer course

Oct 21, 2024, 19:26

Dieter Henrik Heiland: Elena Grabis on ElectroGenomics at EANO2024

Oct 21, 2024, 19:24

Bishal Gyawali: Proud to be an alumnus of the ASCO Leadership Development Program

Oct 21, 2024, 19:21

ESMO E-Learning: Management of HER2-Low Breast Cancers by Paolo Tarantino

Oct 21, 2024, 19:19

Guru Sonpavde: Potentially practice-changing highlights from 2 key Phase III clinical trials